Phase I studies of hypericin, the active compound in St. John's wort, as an antiretroviral agent in HIV-infected adults: AIDS clinical trials group protocols 150 and 258 Academic Article uri icon

Overview

MeSH Major

  • Anti-HIV Agents
  • HIV Infections
  • Perylene

abstract

  • Hypericin caused significant phototoxicity and had no antiretroviral activity in the limited number of patients studied.

publication date

  • March 16, 1999

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed ID

  • 10075619

Additional Document Info

start page

  • 510

end page

  • 4

volume

  • 130

number

  • 6